Double bottom
Right now, I think CAPR still has ways to go prior to the swing pre-entry. It is close to meeting the expected charting target for a short than rebuy. I reiterate the point I have said in the past few days. The fractals and RSI being bearish for the current trend point also makes it seem obvious. As always, please do your own due diligence. Everything I say is on...
Right now looking at CAPR's patterns, it is safe to say that before the next positive retracement wedge, that CAPR should drop at least to the $5.50 range. I think once it does, then it should be getting ready for the a bullish swing. As always, everything I say is on an opinion based basis. Please do your own due diligence and invest at your own risk.
Perfect for quick short term swing trade. Trading STrategy for CAPR Buy @ $4.65 Stop Loss @ $3.99 Sell @ $5.24 Good Luck!
New Capricor Data Reports 100 Percent Survival in Critical COVID-19 patients who were treated with Capricor’s lead asset, off-the-shelf (“allogeneic”) cardiac cell therapy CAP-1002, at Cedars-Sinai Medical Center as part of six compassionate care cases. www.irdirect.net
Hello, What is CAPR? Capricor Therapeutics, Inc. (Nasdaq: CAPR) is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapeutics for the treatment of rare disorders. News Shares of Capricor Therapeutics Inc. (CAPR) are currently down despite the company announcing positive...
If you've followed my work, you know I'm debating between harmonic and classical EW theory. Harmonic is where 5 wave impulses are divided into 3 wave zigzags for waves 1,3,5. Upon further observation it may be that corrective structures like A waves or C waves in zigzags are actually better suited for the harmonic method of counting. Previously, I stated this was...
Might have one more pop after correction is over. W is a double zigzag . I expect Y to be a double zigzag as well. This could stretch to form another double zigzag after Y to get a Z leg down. THere is still alot more downside possible here. The pivot low at the next lowest degree cycle correction is 3.8.
Capricor Therapeutics (CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of Duchenne muscular dystrophy (DMD) and other rare disorders, today announced that it will host a Key Opinion Leader (KOL) call on why exosomes are uniquely suited for vaccine development on Thursday, March...
One of the penny stocks to watch due to its recent performance is that of Capricor Therapeutics Inc (CAPR Stock Report). Back on September 24, the company had been granted a meeting by the United States Food and Drug Administration. " Shares gained as much as 20% as Capricor stock started the week with a bang. It is one of the biotech penny stocks that have...
*******ALERTED TO CAPR ON SPECULATION AND RUMOR WITH HIGH VOLUME AND PRICE SPIKE TO CONFIRM INTEREST, ON CLOSE WATCH FOR COMING DAYS***** AVERAGE ANALYSTS PRICE TARGET $35 AVERAGE ANALYSTS RECOMMENDATION COMPANY PROFILE Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the...
third quarter financial results and corporate update on november 13.